Vivos Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $3.64M, a 50.78% decline year-over-year.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $3.79M.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $7.40M.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $25.36M, a 63039.81% increase year-over-year.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $3.64M, a 74.42% decline from fiscal 2024.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $14.24M, a 415.20% increase from fiscal 2023.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2023 was $2.76M.
- Vivos Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $25.36M, a 955.43% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $3.64M 10-K · filed 2026-04-15 | |
| 2025-06-30 | $3.64M 10-Q · filed 2025-11-19 | |
| 2024-12-31 | $14.24M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $3.79M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $7.40M 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $2.76M 10-K · filed 2025-03-31 | |
| 2021-12-31 | $25.36M 10-K · filed 2023-03-30 | |
| 2021-06-30 | $25.36M 10-Q · filed 2022-12-20 | |
| 2020-12-31 | $2.40M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.82M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $40.17K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $189.51K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $1.17M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |